Literature DB >> 33396797

Relationships of Symptom Groups and Functioning Domains in Patients with Advanced-Stage Non-Small Cell Lung Cancer Undergoing Treatment: A Cross-Sectional Study.

Myung Kyung Lee1.   

Abstract

The purpose of this study was to describe the symptoms experienced by patients with non-small cell lung cancer (NSCLC), examine whether different symptom groups significantly affected different functioning domains in these patients, and determine the effect of the "lack of energy" and "pain" symptom groups on the different functioning domains of health-related quality of life (HRQOL). From a single tertiary institution, this cross-sectional study enrolled 135 consecutive NSCLC patients who were mostly undergoing chemotherapy and were in the advanced stage (National University Hospital, Daegu, South Korea). Clinical and self-reported demographic information and data on different functioning domains (from the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30 (EORTC QLQ-C30)), symptom experience (from the EORTC QLQ-LC13), and the Symptom Distress Scale (SDS) were examined. The four most common symptoms were fatigue (69%), pain (47%), dyspnea (38%), and lack of appetite (36%). The "pain" symptom group was negatively associated with physical, emotional, cognitive, and role functioning. The "lack of energy" symptom group was negatively associated with physical, role, emotional, social, and cognitive functioning. The "lack of energy" symptom group explained the most variance for physical and role functioning, and the "pain" symptom group explained the most variance for emotional functioning. Impaired concentration explained the most variance for cognitive functioning.

Entities:  

Keywords:  fatigue; functioning; lack of energy; lung cancer; pain; quality of life; symptom

Year:  2020        PMID: 33396797      PMCID: PMC7823599          DOI: 10.3390/healthcare9010028

Source DB:  PubMed          Journal:  Healthcare (Basel)        ISSN: 2227-9032


  52 in total

1.  Two-Year Survival Comparing Web-Based Symptom Monitoring vs Routine Surveillance Following Treatment for Lung Cancer.

Authors:  Fabrice Denis; Ethan Basch; Anne-Lise Septans; Jaafar Bennouna; Thierry Urban; Amylou C Dueck; Christophe Letellier
Journal:  JAMA       Date:  2019-01-22       Impact factor: 56.272

2.  The Impact of Baseline Edmonton Symptom Assessment Scale Scores on Treatment and Survival in Patients With Advanced Non-small-cell Lung Cancer.

Authors:  Sharon F McGee; Tinghua Zhang; Hannah Jonker; Scott A Laurie; Glen Goss; Garth Nicholas; Khalid Albaimani; Paul Wheatley-Price
Journal:  Clin Lung Cancer       Date:  2017-06-08       Impact factor: 4.785

3.  Use of Adjuvant Cisplatin-Based Versus Carboplatin-Based Chemotherapy in Non-Small-Cell Lung Cancer: Findings From the Florida Initiative for Quality Cancer Care.

Authors:  Tawee Tanvetyanon; Ji-Hyun Lee; William J Fulp; Fred Schreiber; Richard H Brown; Richard M Levine; Thomas H Cartwright; Guillermo Abesada-Terk; George P Kim; Carlos Alemany; Douglas Faig; Philip V Sharp; Merry-Jennifer Markham; Mokenge Malafa; Paul B Jacobsen
Journal:  J Oncol Pract       Date:  2015-05-19       Impact factor: 3.840

4.  Health-related quality of life in patients with lung cancer: validation of the Mexican-Spanish version and association with prognosis of the EORTC QLQ-LC13 questionnaire.

Authors:  Óscar Arrieta; Carolina Núñez-Valencia; Leonardo Reynoso-Erazo; Salvador Alvarado; Diana Flores-Estrada; Laura Patricia Angulo; Luis F Oñate-Ocaña
Journal:  Lung Cancer       Date:  2012-03-03       Impact factor: 5.705

5.  Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms.

Authors:  Xin Shelley Wang; Diane L Fairclough; Zhongxing Liao; Ritsuko Komaki; Joe Y Chang; Gary M Mobley; Charles S Cleeland
Journal:  J Clin Oncol       Date:  2006-09-20       Impact factor: 44.544

6.  Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer.

Authors:  Timothy Winton; Robert Livingston; David Johnson; James Rigas; Michael Johnston; Charles Butts; Yvon Cormier; Glenwood Goss; Richard Inculet; Eric Vallieres; Willard Fry; Drew Bethune; Joseph Ayoub; Keyue Ding; Lesley Seymour; Barbara Graham; Ming-Sound Tsao; David Gandara; Kenneth Kesler; Todd Demmy; Frances Shepherd
Journal:  N Engl J Med       Date:  2005-06-23       Impact factor: 91.245

7.  Pain reports by older hospice cancer patients and family caregivers: the role of cognitive functioning.

Authors:  Rebecca S Allen; William E Haley; Brent J Small; Susan C McMillan
Journal:  Gerontologist       Date:  2002-08

8.  Features of fatigue in patients with early-stage non-small cell lung cancer.

Authors:  Xianping Huang; Weihe Zhou; Yuefeng Zhang
Journal:  J Res Med Sci       Date:  2015-03       Impact factor: 1.852

Review 9.  Interventional Analgesic Management of Lung Cancer Pain.

Authors:  Uri Hochberg; Maria Francisca Elgueta; Jordi Perez
Journal:  Front Oncol       Date:  2017-02-14       Impact factor: 6.244

10.  Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016.

Authors:  Kyu-Won Jung; Young-Joo Won; Hyun-Joo Kong; Eun Sook Lee
Journal:  Cancer Res Treat       Date:  2019-03-18       Impact factor: 4.679

View more
  1 in total

Review 1.  Therapeutic potential of chrysin nanoparticle-mediation inhibition of succinate dehydrogenase and ubiquinone oxidoreductase in pancreatic and lung adenocarcinoma.

Authors:  Eman M Ragab; Doaa M El Gamal; Tarek M Mohamed; Abeer A Khamis
Journal:  Eur J Med Res       Date:  2022-09-08       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.